Ann Surg Oncol. 2026 Apr 2. doi: 10.1245/s10434-026-19458-8. Online ahead of print.
ABSTRACT
BACKGROUND: This study aimed to compare the perioperative and oncologic outcomes between robotic and open retroperitoneal lymph node dissection in patients with testicular cancer.
METHODS: The study was conducted in accordance with the PRISMA guidelines, and quality assessment was performed following the AMSTAR criteria. A systematic search was performed in Embase, PubMed, and Web of Science databases, with the search period up to July 2025. Statistical analysis was performed using Stata 17 software.
RESULTS: The current results showed that compared with open retroperitoneal lymph node dissection (O-RLND), robotic retroperitoneal lymph node dissection (R-RPLND) had a shorter hospital length of stay (effect, – 3.68; 95 % confidence interval [CI], – 4.16 to – 3.21; P < 0.05), less estimated blood loss (effect, – 296.09; 95 % CI, – 416.62 to – 175.55; P < 0.05), and a lower overall complication rate (relative risk, 0.66; 95 % CI, 0.49-0.89; P < 0.05). Lymph node production and recurrence rate did not differ significantly between the two.
CONCLUSION: Robotic retroperitoneal lymph node dissection appears to be safer than O-RLND and has a faster postoperative recovery. Oncologic outcomes did not differ significantly, but more research is needed to explore further.
PMID:41927958 | DOI:10.1245/s10434-026-19458-8